Loading data for ARCT — first visit, this takes a few seconds.
Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM: ARCT
· 即時價格 · USD
15.82
+0.26 (1.67%)
收盤價： Sep 08, 2026, 3:37 PM
股價、關鍵數字和最新消息，都在這一頁。
Arcturus Therapeutics Holdings Inc.（ARCT）股價、分析與資料
無可用資料
| 買價 | 4.43 |
| 市值 | 439M |
| 營收 (ttm) | 29.4M |
| 淨利（ttm） | -93.3M |
| 2.48 | |
| -3.33 | |
| n/a | |
| -4.28 | |
| P/B (ttm) | 2.56 |
| P/S (ttm) | 14.96 |
| 財報日期 | Nov 9, 2026 |
| 賣價 | 7.96 |
| 成交量 | 534,617 |
| 20 日平均成交量 | 825,968 |
| 開盤價 | 15.61 |
| 前收盤價 | 15.56 |
| 當日區間 | 15.40 - 16.02 |
| 52 週範圍 | 5.50 - 24.17 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 ARCT
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which ...
完整的公司簡介財務表現
Arcturus Therapeutics s 在 2025 年的營收為 67.22M，較前一年的 138.39M 減少 -51.43%。 淨利為 -65.78M，較前期減少 -18.73%。
財務報表財報驚奇
Arcturus Therapeutics s 已於 Aug 6, 2026 公布季度財報：
- 營收為 $880K 低於預期 $0, 年增 -96.41% 下滑.
- 每股盈餘為 -0.84 超出預期 0.19, 年增 -147.06% 下滑.
第 1 頁，共 2 頁